FDA clears Medtronics stent for use in iliac arteries
Medtronic has received FDA approval for the Complete SE vascular stent system to be used for the treatment of peripheral arterial disease in the iliac arteries.
The Complete SE vascular stent system features a dual-deployment delivery system with a triaxial design, according to the Minneapolis-based company. The new delivery system is made up of an inner shaft, a retractable sheath and a stabilizing sheath.
Robert Molnar, MD, of Michigan Vascular Research Center in Flint, and William Gray, MD, director of endovascular intervention at New York-Presbyterian Hospital/Columbia University Medical Center in New York City, led the study (as co-principal investigators) that contributed to this approval.
The Complete SE vascular stent system features a dual-deployment delivery system with a triaxial design, according to the Minneapolis-based company. The new delivery system is made up of an inner shaft, a retractable sheath and a stabilizing sheath.
Robert Molnar, MD, of Michigan Vascular Research Center in Flint, and William Gray, MD, director of endovascular intervention at New York-Presbyterian Hospital/Columbia University Medical Center in New York City, led the study (as co-principal investigators) that contributed to this approval.